Dipyridamole inhibits red cell-induced platelet activation
- 1 April 1989
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 76 (2-3) , 149-154
- https://doi.org/10.1016/0021-9150(89)90098-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Red blood cells mediate spontaneous aggregation of platelets in whole bloodAtherosclerosis, 1987
- Inhibitors of “spontaneous” platelet aggregation in whole bloodAtherosclerosis, 1985
- Further studies on the role of red blood cells in spontaneous platelet aggregationThrombosis Research, 1985
- Platelet aggregation studies in whole human bloodThrombosis Research, 1983
- Mechanism of action of dipyridamoleThrombosis Research, 1983
- A study of the stimulation of human venous prostacyclin synthesis by dipyridamoleThrombosis Research, 1982
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel WallsNew England Journal of Medicine, 1979
- Mode of action of dipyridamole on human plateletsThrombosis Research, 1979
- pH and temperature dependence of adenosine uptake in human erythrocytesEuropean Journal of Pharmacology, 1978
- DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLINThe Lancet, 1978